DAVITA INC. Share Repurchase Authorization
DAVITA INC. (DVA) had Share Repurchase Authorization of $2.00 billion as of 2025-08-21, per its 10-K filed 2026-02-11.
Financial Statements › Notes
srt:StockRepurchaseProgramAuthorizedAmount1 · last filed 2026-02-11
- 2025-08-21: Stock Repurchase Program Authorized Amount1 $2.00B.
- 2024-09-05: Stock Repurchase Program Authorized Amount1 $2.00B.
- 2021-12-17: Stock Repurchase Program Authorized Amount1 $2.00B.
| Period end | Stock Repurchase Program Authorized Amount1 |
|---|---|
| 2025-08-21 | $2.00B 10-K · filed 2026-02-11 |
| 2024-09-05 | $2.00B 10-K · filed 2026-02-11 |
| 2021-12-17 | $2.00B 10-Q · filed 2024-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |